# Mipharm S.p.A. - Inspection Records

Source: https://www.keypedia.com/companies/mipharm-spa/5bbbfcd9-7f44-434e-a097-60a4d9f446bc

> Inspection records and compliance data for Mipharm S.p.A. in Milan, None. Access full analysis and detailed observations.

---

## Details

- Name: Mipharm S.p.A.
- FEI Number: 3002807647
- City: Milan
- State: None
- Country Name: Italy
- Address Line 1: Via Bernardo Quaranta 12
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - Mipharm S.p.A. - 2023-09-22](https://www.keypedia.com/records/483/mipharm-spa/9d89b701-a9bc-4852-b1b3-9a38b7eae3ab) — source: FDA, date: September 22, 2023
- [FDA Inspection 1219480 - Mipharm S.p.A. - 2023-09-22](https://www.keypedia.com/records/fda_inspections/mipharm-spa/cc148a53-3099-4984-9987-6d1113bbbb60) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 22, 2023
- [FDA Inspection 1133100 - Mipharm S.p.A. - 2019-10-17](https://www.keypedia.com/records/fda_inspections/mipharm-spa/398b9b61-4d48-4bac-9f12-df0b1773d001) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 17, 2019
- [FDA Inspection 1004998 - Mipharm S.p.A. - 2017-02-03](https://www.keypedia.com/records/fda_inspections/mipharm-spa/6079ccf1-30c3-4af0-b5a6-e75d46f17ad5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 3, 2017
- [FDA Inspection 870680 - Mipharm S.p.A. - 2014-02-14](https://www.keypedia.com/records/fda_inspections/mipharm-spa/168d2990-bd91-4ba8-b801-7274b0cae576) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 14, 2014
- [FDA Inspection 853837 - Mipharm S.p.A. - 2013-09-27](https://www.keypedia.com/records/fda_inspections/mipharm-spa/03d4b092-b607-4c35-8495-83aa1c6caf0b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 27, 2013
- [FDA Inspection 731940 - Mipharm S.p.A. - 2011-06-10](https://www.keypedia.com/records/fda_inspections/mipharm-spa/54984874-0510-49b1-8fc3-a0095693469e) — classification: No Action Indicated (NAI), source: FDA, date: June 10, 2011

## Related Companies

- [Ingenus Pharmaceuticals NJ, LLC.](https://www.keypedia.com/companies/ingenus-pharmaceuticals-nj-llc/542b7622-3ecf-48db-9fc6-0edf6cc42665)
- [Becton Dickinson Infusion Therapy Systems, Inc.](https://www.keypedia.com/companies/becton-dickinson-infusion-therapy-systems-inc/d0e73e32-eca1-4137-8dfc-d6bde32ba0aa)
- [AstraZeneca AB](https://www.keypedia.com/companies/astrazeneca-ab/b85a1aa5-9a0c-4c1e-996d-70b40b2507de)
- [Summit Biosciences Inc.](https://www.keypedia.com/companies/summit-biosciences-inc/2dadddc5-06ce-43be-914b-1b6e9a76e976)
- [Eisai, Inc.](https://www.keypedia.com/companies/eisai-inc/1e0d6af4-f962-4ac0-826f-90ce5f71a0a3)
- [Cosette Pharmaceuticals NC Laboratories, LLC](https://www.keypedia.com/companies/cosette-pharmaceuticals-nc-laboratories-llc/4f90e360-99ea-4457-a022-4950a8ea7644)
- [Sanofi Winthrop Industrie](https://www.keypedia.com/companies/sanofi-winthrop-industrie/88a4c8ee-d792-4747-acb7-de304d1efbb6)
- [Actavis Laboratories FL, Inc.](https://www.keypedia.com/companies/actavis-laboratories-fl-inc/7c50db23-6cc7-4100-bc80-c02d3aa7f85a)
- [Haleon US Holdings LLC](https://www.keypedia.com/companies/haleon-us-holdings-llc/adf0ad1b-ed79-4d72-a254-d42d5a982384)
- [Colgate-Palmolive Company](https://www.keypedia.com/companies/colgate-palmolive-company/7db665f6-094f-4de5-bf3b-c2528e2a223b)

## Related Officers

- [Consumer Safety Officer](https://www.keypedia.com/people/rajiv-r-srivastava/05b42bfd-0cf4-42ce-89e1-b81bf36eaa17)